Loading...

Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Combination therapy with immune checkpoint inhibitors (ICIs) has been applied in the clinic to achieve synergistic effects and to improve clinical efficacy. Compared with monotherapy, combination therapy has promising efficacy against various advanced cancers. To further verify the effec...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Yang, Yi, Jin, Gang, Pang, Yao, Huang, Yijie, Wang, Wenhao, Zhang, Hongyi, Tuo, Guangxin, Wu, Peng, Wang, Zequan, Zhu, Zijiang
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033417/
https://ncbi.nlm.nih.gov/pubmed/32116716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00040
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!